Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-25 @ 5:11 AM
NCT ID:
NCT04505527
Eligibility Criteria:
Inclusion Criteria:
Subjects must
* be aged between 19 and 35 for the young adult group
* be over 65 years of age for the older adult groups
* be independently residing in the community
* be able to provide informed consent
* be able to walk independently without an assistive device or 30 minutes in three-minute sections interspersed with rest periods.
The older participants must either have sustained two or more falls in the past year (i.e. Fallers) or not have sustained any falls in the past year (i.e. Non-Fallers).
Exclusion Criteria:
* Neurological disorder or progressive neurologic condition - epilepsy, Alzheimer disease and other dementias, stroke, multiple sclerosis, Parkinson's disease, brain infections, brain tumors.
* Movement disorder - ataxia, dystonia, Huntington's disease, myoclonus, Parkinson disease, progressive supranuclear palsy, Wilson disease.
* History of Cardiovascular events this includes any history of heart problems (such as heart attack, chest pain, or conditions which affect the heart's muscles, valves, or rhythm)
* Current injury or moderate to severe pain affecting the lower limbs, pelvis, back, trunk.
* Surgery within the past 6 months.
* Current participation in any other study that involves walking, balance, or training.
Medications will not prevent inclusion in the study however they will be recorded to enable consideration in subsequent post-hoc analyses.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
19 Years
Maximum Age:
90 Years
Study:
NCT04505527
Study Brief:
Protocol Section:
NCT04505527